1. Home
  2. Mutual Funds
  3. Biotechnology

RYOIX

Biotechnology

Price $65.65
Change $0.15 / 0.23%
As of 12/24/24
 
Resources
Fact Card
Prospectus
Summary Prospectus
 
Semi-Annual TSR
Semi-Annual Financial Report
Annual Financial Report

Investment Strategy

Seeks to provide capital appreciation by investing in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services.

Fund Highlights and Applications

  • Focused Biotechnology Exposure. Provides targeted exposure to the biotechnology industry yet minimizes single stock risk.
  • Modified Cap Weighted Approach. Seeks to capture the influences of both larger-and smaller cap-weighted companies, not just the largest companies in the sector.
  • Transparent. Holdings for each Rydex sector funds are available online daily.

Industry Breakdown

Distributions
Most Recent Income $9.422766
Dividend $0.000000
Most Recent Capital Gain $9.422766

Fees and Expenses
Gross Expense Ratio 1.43%
Net Expense Ratio 1.40%  

Symbols & CUSIPs

Class Symbol CUSIP Inception
A RYBOX 78355E353 9/1/04
C RYCFX 783554280 3/30/01
Inv RYOIX 783554827 4/1/98
H RYOAX 783554835 4/1/98

Investment Team

Team Managed 

Operations

Fund Type Rydex
Distribution Frequency Annual (if applicable)
Benchmark
Telephone 800.820.0888
Trading Hours Phone: 9:30 AM - 3:30 PM ET
Web: 9:30 AM - 3:50 PM ET
Note: Each financial intermediary may have its own rules about shares transactions, and may have earlier cut - off times for processing your transaction.
Investment Adviser Security Investors, LLC
Distributor Guggenheim Funds Distributors, LLC
Performance displayed represents past performance which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Current performance may be lower or higher than the performance data quoted. Returns for performance under one year are cumulative, not annualized.  Performance shown reflects maximum sales charges or contingent deferred sales charges (CDSC) as applicable. Class A-shares have a maximum sales charge of 4.75%. Class C-shares have a maximum CDSC of 1% for shares redeemed within 12 months of purchase.

Data is subject to change on a daily basis. Partial year returns are cumulative, not annualized. Returns reflect the reinvestment of dividends.

This fund may not be suitable for all investors. •Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds’ holdings in issuers of the same or similar offerings. •The fund may invest in American Depositary Receipts (“ADRs”) therefore subjecting the value of the fund’s portfolio to fluctuations in foreign exchange rates. •The fund is subject to active trading risks that may increase volatility and impact the fund’s ability to achieve its investment objective. •This fund is considered non-diversified and can invest a greater portion of its assets in securities of individual issuers than a diversified fund. As a result, changes in the market value of a single security could cause greater fluctuations in the value of fund shares than would occur in a more diversified fund.
Subscribe to Our Perspectives
 
PRIVACY POLICY
BUSINESS CONTINUITY
LEGAL INFORMATION
Your Privacy Rights

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.

Investing involves risk, including the possible loss of principal.

Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.

© 2024 Guggenheim Investments. All Rights Reserved.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value

This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.